Results 231 to 240 of about 32,982 (330)

The role of local ablative therapy in patients with advanced invasive mucinous adenocarcinoma of the lung. [PDF]

J Cancer Res Clin Oncol
Kim SH, Seong H, Lee J, Ahn HY, Cho JS, I H, Kim YD, Lee MK, Eom JS, Kim MH.   +9 more
europepmc   +1 more source

Visibility evaluation of gastric epithelial neoplasm of fundic gland mucosa lineage using texture and color enhancement imaging

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objectives Recently, the incidence of Helicobacter pylori‐uninfected gastric cancers, such as gastric epithelial neoplasm of fundic‐gland mucosa lineage (GEN‐FGML), has increased with the widespread use of eradication therapy. Because the detection and endoscopic diagnosis of GEN‐FGML are difficult, an effective observation method in screening
Hisanori Utsunomiya, Hiroya Ueyama, Tsutomu Takeda, Shunsuke Nakamura, Yasuko Uemura, Tomoyo Iwano, Momoko Yamamoto, Ryota Uchida, Daiki Abe, Shotaro Oki, Nobuyuki Suzuki, Atsushi Ikeda, Yoichi Akazawa, Kumiko Ueda, Mariko Hojo, Shuko Nojiri, Takashi Yao, Akihito Nagahara   +17 more
wiley   +1 more source

Establishment and verification of novel TNM staging system for lung mucinous adenocarcinoma. [PDF]

BMC Cancer
Ge QY, Zheng C, Zhang GC, Cong ZZ, Luo J, Xu Y, Wang CY, Luo C, Wei W, Yang ZH, Li MZ, Wu YH, Wang YY, Xue Q, Shen Y.   +14 more
europepmc   +1 more source

Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma

, 2010
Arun Mavanur, Vamsi Parimi, Mark E. O’Malley, Marina N. Nikiforova, David L. Bartlett, Jon M. Davison   +5 more
openalex   +2 more sources

Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications

Immunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
Immune checkpoint molecules are today's leading targets for immunotherapy, especially in the field of cancer. This review summarizes the most important and recent advances in this field and in different types of cancer. ABSTRACT Background Today, treating cancer patients with monoclonal antibodies (mAbs), by targeting immune checkpoints, is one of the ...
Erfan Rezazadeh‐Gavgani, Reza Majidazar, Parisa Lotfinejad, Tohid Kazemi, Ali Shamekh   +4 more
wiley   +1 more source

Assessing the Value of ⁶⁸Ga-FAPI PET/CT in Gastric Mucinous Adenocarcinoma or Signet Ring Cell Carcinoma. [PDF]

Radiol Imaging Cancer
Sun Y, Xu J, Qiao Y, Zhang J, Pan H, Xu X, Song S.   +6 more
europepmc   +1 more source

Mucinous Adenocarcinoma of the Thymus: a Case Report

, 2010
Tsuyoshi Yachi, Yoshio Tsunezuka, Ryuuichi Waseda, Takeshi Kobayashi, Yukiko Uno, Makiko Minami, Ayako Katagiri, Hiroshi Kurumaya, Kazuyoshi Katayanagi   +8 more
openalex   +2 more sources

Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma

Journal of Extracellular Vesicles, Volume 14, Issue 4, April 2025.
Zhao et al. explored the utility of small extracellular vesicles (sEVs) for early detection of pancreatic ductal adenocarcinoma (PDAC) using oncofetal chondroitin sulfate (ofCS) as a specific marker for cancer cell‐derived sEVs. For detecting early‐stage PDAC among healthy individuals and patients with non‐malignant disease, ROC analysis revealed an ...
Yaru Zhao, Chenlei Wen, Qi Wang, Yue Qing, Serena Tondi, Chiara Reina, Berina Šabanović, Cherry Yin‐Yi Chang, Chu‐Hu Lai, Huimin Wang, Mette Ø. Agerbaek, Thomas M. Clausen, Tobias Gustavsson, Thor G. Theander, Ali Salanti, Clara Csilla Meny, Baiyong Shen, Alexandra Aicher, Jiajia Tang, Christopher Heeschen   +19 more
wiley   +1 more source

Construction and validation of prognostic model for colorectal mucinous adenocarcinoma patients and identification of a new prognosis related gene FAM174B. [PDF]

Transl Cancer Res
Tan X, Fang Q, Xu Y, Li S, Yuan J, Xu K, Chen X, Fu G, Liu Y, Huang Q, Peng X, Xiao S.   +11 more
europepmc   +1 more source

Pancreatic Cancer: Pathogenesis and Clinical Studies

MedComm, Volume 6, Issue 4, April 2025.
Although the treatment landscape for cancer has evolved rapidly in recent years, progress has stagnated for pancreatic cancer (PC). PC includes multiple types, but pancreatic ductal adenocarcinoma (PDAC) accounts for >90% of cases. This review focuses on the molecular pathogenesis and different treatments for PDAC, hoping to propose future directions ...
Kexun Zhou, Yingping Liu, Chuanyun Tang, Hong Zhu   +3 more
wiley   +1 more source